New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Pernix Therapeutics HLDG (PTX)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-DEC
2008
31-MAR
2009
30-JUN
2009
30-SEP
2009
31-DEC
2009
Total Revenue
35.1K
0
0
0
0
Gross Profit
-265K
0
-340K
-402K
-419K
Research & Development
0
0
0
0
0
SG&A
0
0
0
0
0
Amortization & Deprec
0
0
0
0
0
Other Expenses
35.1K
-
-
-
-
Total Operating Expenses
35.1K
-
-
-
-
Operating Income
0
0
0
0
0
Other Income
-
-
-
-
-
EBIT
-265K
-368K
-318K
-383K
681K
Minority Interest
0
0
0
0
0
Interest Expense
1328
0
0
0
2376
Income Before Taxes
-266K
-368K
-318K
-383K
678K
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
-266K
-368K
-318K
-383K
678K
Income - Discontinued Ops
-140K
1.03M
0
0
-1.16M
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-407K
660K
-318K
-383K
-480K
Preferred Dividends
0
0
0
0
0
Net Income to Common
-407K
660K
-318K
-383K
-480K
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour